HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhiro Tsukada Selected Research

Intravenous Administration

2/2002A new pseudo-peptide of Arg-Gly-Asp (RGD) inhibits intrahepatic metastasis of orthotopically implanted murine hepatocellular carcinoma.
2/2002Therapeutic and analysis model of intrahepatic metastasis reflects clinical behavior of hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuhiro Tsukada Research Topics

Disease

45Neoplasms (Cancer)
01/2017 - 02/2002
17Neoplasm Metastasis (Metastasis)
07/2016 - 02/2002
13Carcinoma (Carcinomatosis)
02/2017 - 06/2002
10Stomach Neoplasms (Stomach Cancer)
02/2017 - 11/2004
8Esophageal Neoplasms (Esophageal Cancer)
04/2016 - 07/2009
6Breast Neoplasms (Breast Cancer)
04/2016 - 07/2006
6Colorectal Neoplasms (Colorectal Cancer)
12/2014 - 04/2004
6Pancreatic Neoplasms (Pancreatic Cancer)
11/2014 - 11/2004
5Esophageal Squamous Cell Carcinoma
05/2016 - 12/2012
4Hepatocellular Carcinoma (Hepatoma)
06/2014 - 02/2002
3Circulating Neoplastic Cells
01/2017 - 08/2013
3Fatty Liver
02/2016 - 01/2012
3Adenocarcinoma
12/2013 - 06/2002
3Inflammation (Inflammations)
12/2013 - 12/2008
3Biliary Tract Neoplasms (Biliary Tract Cancer)
07/2013 - 01/2008
3Bile Duct Neoplasms (Bile Duct Cancer)
01/2008 - 01/2008
2Reperfusion Injury
02/2016 - 01/2012
2Lymphatic Metastasis
01/2015 - 11/2004
2Colonic Neoplasms (Colon Cancer)
03/2014 - 11/2013
2Carcinogenesis
06/2012 - 09/2009
2Non-alcoholic Fatty Liver Disease
01/2012 - 01/2010
2Hyperthermia
06/2009 - 03/2002
2Pancreaticobiliary Maljunction
01/2008 - 01/2008
2Jaundice (Icterus)
01/2008 - 01/2008
2Gallbladder Neoplasms (Gallbladder Cancer)
01/2008 - 01/2008
1Triple Negative Breast Neoplasms
03/2017
1Drug-Related Side Effects and Adverse Reactions
07/2016
1Aspiration Pneumonia
05/2016
1Sarcoma (Soft Tissue Sarcoma)
07/2015
1Small Cell Carcinoma
02/2015
1Infections
01/2015
1Hemolysis
01/2015
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/2015
1Anemia
01/2015
1Thrombosis (Thrombus)
01/2015
1Bile Reflux
12/2013
1Barrett Esophagus (Barrett's Esophagus)
12/2013

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
03/2014 - 04/2004
4Pharmaceutical PreparationsIBA
07/2016 - 06/2009
4ChemokinesIBA
12/2014 - 05/2008
4GemcitabineFDA Link
11/2014 - 02/2005
4Messenger RNA (mRNA)IBA
12/2008 - 06/2002
4Matrix Metalloproteinases (MMPs)IBA
05/2008 - 02/2002
3Biomarkers (Surrogate Marker)IBA
03/2017 - 11/2013
3Epithelial Cell Adhesion MoleculeIBA
01/2017 - 02/2016
3Cisplatin (Platino)FDA LinkGeneric
05/2016 - 02/2002
3Phosphates (Orthophosphate)IBA
04/2016 - 02/2004
3MicroRNAs (MicroRNA)IBA
02/2015 - 07/2011
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2015 - 08/2012
3Chemokine CXCL16IBA
12/2014 - 05/2007
3ThromboxanesIBA
03/2014 - 02/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
06/2009 - 02/2002
2Antineoplastic Agents (Antineoplastics)IBA
07/2016 - 10/2015
2Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
05/2016 - 02/2016
2Choline (Choline Chloride)IBA
02/2016 - 12/2013
2IronIBA
02/2016 - 04/2009
2Methionine (L-Methionine)FDA Link
02/2016 - 12/2013
2Thromboxane A2 (A2, Thromboxane)IBA
03/2014 - 06/2006
2Indicators and Reagents (Reagents)IBA
01/2014 - 03/2008
2Chemotactic FactorsIBA
03/2013 - 09/2009
2Complementary DNA (cDNA)IBA
01/2013 - 07/2009
2Aquaporins (Water Channels)IBA
06/2012 - 03/2009
2Adenosine Triphosphatases (ATPase)IBA
07/2010 - 04/2004
2Ouabain (G Strophanthin)IBA
07/2010 - 04/2004
2phytobacteriomycin (PBM)IBA
01/2008 - 01/2008
2Interferon-betaIBA
01/2006 - 02/2005
2Peptide Hydrolases (Proteases)FDA Link
03/2005 - 05/2003
2N- hydroxy- 5- ethoxymethyloxy- 2- methyl- 4- (4- phenoxybenzoyl)aminopentanamideIBA
05/2003 - 02/2002
1Transcription Factor 4IBA
02/2017
1Plant Preparations (Preparation, Plant)IBA
07/2016
1ferrous citrateFDA Link
02/2016
1AcidsIBA
02/2016
1EnzymesIBA
07/2015
1AnticoagulantsIBA
01/2015
1eculizumabFDA Link
01/2015
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
06/2014
1Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA
06/2014
16- cyano- 4- (N- ethylsulfonyl- N- methylamino)- 3- hydroxy- 2,2- dimethylchromaneIBA
03/2014
1STA 2IBA
03/2014

Therapy/Procedure

11Therapeutics
07/2016 - 02/2002
7Drug Therapy (Chemotherapy)
01/2017 - 01/2008
5Esophagectomy
01/2015 - 01/2006
4Hepatectomy
06/2014 - 10/2007
4Gastrectomy
12/2013 - 03/2004
3Stents
01/2008 - 10/2005
2Lab-On-A-Chip Devices
04/2016 - 08/2013
2Laparoscopic Cholecystectomy
01/2015 - 01/2008
2Neoadjuvant Therapy
11/2014 - 03/2008
2Cholecystectomy
01/2008 - 01/2008
2Pancreaticoduodenectomy
01/2008 - 01/2008
2Gastric Bypass (Roux-en-Y Gastric Bypass)
11/2007 - 11/2004
2Lymph Node Excision (Lymph Node Dissection)
03/2004 - 08/2002
2Intravenous Administration
02/2002 - 02/2002
1Phytotherapy (Herbal Therapy)
07/2016
1Kampo Medicine (Kampo)
07/2016
1Oral Administration
07/2016
1Length of Stay
05/2016
1Perioperative Care
01/2015
1Compression Stockings
01/2015
1Adjuvant Chemotherapy
02/2014